About Andrew Danielson
Andrew Danielson is a director at Qlaris Bio.
Andrew Danielson first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Andrew Danielson in the role, so the role may have started earlier or lasted longer.
Qlaris Bio, Inc.
Director
2024 – 2026 · Dedham, MA
Develops glaucoma treatments for patients with the eye disease.
Key Colleagues at Startups
The people Andrew Danielson works with at each company, as listed on that company's latest Form D.
Qlaris Bio, Inc. · Form D, Jun 17, 2026
BW
Barbara Wirostko
Executive officer
AG
Adrienne Graves
Director
WH
Wende Hutton
Director
RW
Robert Warner
Director
FG
Frederic Guerard
President and Chief Executive Officer, director
RH
Ronald Hunt
Director